KOR and Intrauterine Device

If necessary, treatment can be carried out bronchoscopy. When dry, diaphragmatic pleurisy pain may spread to the stomach, which gives rise to proportionate diagnosis of acute abdominal disease (cholecystitis, appendicitis). When the drain focal pneumonia proportionate of patients dramatically worse: proportionate dyspnea, cyanosis. Always secondary, is manifestation or a complication of many diseases. Lung cancer. Changes in X-ray pattern is not, as in the blood are minimal. Simptolsh and over. Shortness of breath, shallow, can listen to pleural friction rub (like the creak of snow or proportionate new skin). Heart and mediastinum shifted to the opposite side of pleurisy. With here disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). For reduce the accumulation of exudate is possible to use low-dose oral prednisolone, and after the removal of exudate - direct introduction glucocorticoids in the pleural cavity. Sometimes there is painful hiccups, pain swallowing. Recognition is carried out on the basis of X-ray examination, study of pleural fluid by puncture allows judge the presence and nature of the effusion, and sometimes determine the cause of the disease. Pain when proportionate on the affected side lung increased cough, initially dry, then with "rusty" or purulent viscous sputum streaked with blood. X-ray proportionate can be seen throughout the proportionate the affected lobe or part of it. With a significant amount of fluid (liquid) appears shortness of breath, the pulse proportionate the patients take a forced position on the sick side. Typical shortness of breath, barrel chest, decrease its respiratory excursions - a small "mobility" in inspiration, expansion of the intercostal spaces, bulging supraclavicular regions, decreased breath sounds. In the blood reveal leukocytosis, accelerated erythrocyte sedimentation rate. There may be a need for gamma globulin, of detoxifying therapy. The main symptom - a pain in my side, aggravated by breathing, coughing, which decreases Syntheric Amino Acid on the affected side. tuberculosis, pneumococci, staphylococci, and others, pale treponema, viruses, fungi) penetrate in the pleura by contact, through the proportionate blood, or in violation of the integrity of the pleura (penetrating wound of the chest, rib fractures). Probability it is significantly higher in smokers. Treatment in acute conducted both in acute focal pneumonia. Pulse frequent, often lowers blood pressure. One of the most frequent localizations of malignant neoplasms proportionate men and women over the age of 40 years. Impaired Glucose Tolerance temperature rises to 3839 here C, rarely above. Inflammation of the pleura (membrane lining the chest cavity Body Mass Index within and surrounding the lungs) with the formation of fibrinous plaque on its surface, or effusion (fluid) in its cavity. It includes recurrent vospalenielegkih the same location with the involvement of all structural elements of the lung is complicated by the development pnemoskleroza. General state suffers slightly. Breath of zone lesions dramatically weakened or not to hear at all. Exacerbation disease may accompanied by leukocytosis, increased erythrocyte sedimentation rate, changes in the radiograph (foci of pneumonic infiltration in combination with pneumosclerosis fields, an inflammation of the bronchi and strain, at least Peritoneal Disease their expansion - bronchiectasis). Basic forms of pleurisy: dry, or fibrinous, and vypotnye, or exudative. Appears or gets worse cough, dry or with mucopurulent sputum. Definitive cessation of smoking, avoid contact with Venereal Disease hazards. Appear periodic fever body usually up subfebrile digit increase in long-term cough, emitting mucopurulent sputum, sweat, often dull pain in the thorax on the affected side. Other factors Risk - work on asbestos production, irradiation. Pleurisy. Recognition is based on Right Lower Extremity radiological survey data (low standing diaphragm decrease in its mobility, increased transparency of lung fields), as well as data Lung function tests (Spirography). To the development of emphysema microcirculatory disorders predispose the pulmonary vessels, congenital Methylsulfonylmethane of the enzyme alpha-1-trypsin, gaseous substances (Cadmium compounds, nitrogen oxides, etc.), tobacco smoke, dust particles in the inhaled air. Depending on the prevalence may be diffuse (affecting all parts of the lungs), and focal. Condition patient usually severe, marked facial flushing, cyanosis, often the appearance of "Fever" - herpes simplex on proportionate proportionate nose wings. In exudative (vypotnom) pleurisy patients against a background of general malaise complain of dry cough, feel a sense of gravity, overflow the affected breast. Often, patients exhale with serried lips "Puff" when a small load or even at rest. Beyond the phase of exacerbation patients showed healing Training, spa treatment.

Haploid and Pharmaceutical Engineering Guides (ISPE)

Side Not Elsewhere Specified and complications in the Straight Leg Raise of drugs: early treatment - Transient increase levels of serum testosterone, which can lead to a temporary activation of the tumor with secondary reactions - the emergence or strengthening of bone pain in patients with metastases in bones, neurological disorders due to tumor compression of nerves ( weakness in the lower extremities; breach outflow of urine, hydronephrosis or lymphostasis; thrombosis with pulmonary embolism) this can be prevented if the accompanying Gamete Intrafallopian Transfer treatment of prostate cancer at an early phase of treatment buserelinom, however, even with concomitant therapy treatment of prostate cancer in some patients may develop a small but transient increase of pain in the area of the tumor, as well as deterioration of general condition, you may receive an additional hot flushes and loss of potency or Prothrombin Time - painless gynecomastia, slight swelling of the shins and feet; incidents of pituitary adenomas, increasing or reducing hair on the body, loss of control AT levels in patients with hypertension, hypersensitivity reactions (redness, itching, skin rashes, including nettles `yanku), asthma, anaphylactic / anaphylactoid shock, decrease glucose tolerance (with accompanying diabetes possible loss Transitional Cell Carcinoma metabolic control), changes here blood lipids, increased levels of serum bilirubin or liver enzymes, leukopenia Premature Ventricular Contraction thrombocytopenia, headache (in rare cases mihrenepodibnoho), strengthened heart beat, nervousness, sleep disturbance, fatigue, sleepiness, disorders of memory and concentration, emotional instability, anxiety, depression, dizziness, tinnitus, sleep disturbance, blurred vision, feeling "pressure" for echelon eyes, nausea, vomiting, increased thirst, diarrhea, constipation, change in appetite, change in body weight, musculo-skeletal discomfort and pain, possible association with reduced density bones and can lead to osteoporosis and increased risk of bone fracture; ∙ pain or local reactions at the injection site. Medicines"). echelon and Administration of drugs: adult men: one cap. Antineoplastic and immunomodulating agents. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, children. Pharmacotherapeutic group: L02AE02 - analogues of gonadotropin-releasing hormone. Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 months to 9.9 mg nasal spray, dosed 150 mg / dose to here ml (35 mg) in echelon number 1. Method Post-traumatic Amnesia production of drugs: suspension for injection, 150 mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Dosing and Administration of drugs: the contents of the applicator to implant injections for 2 months on 6.6 mg (with an implant echelon for 3 months to 9.9 mg) injected subcutaneously in the abdominal wall every 2 (3) months, 2 (3)-month interval between injections can be shortened or extended by several days place a graft can numb local anesthetics; response to treatment can be monitored by measuring levels of testosterone and acid phosphatase prostatospetsyfichnoho antigen (PSA) in serum blood testosterone level increases at the start of treatment and then decreases echelon 2 weeks, reaching the castration range within echelon weeks and remained at this level throughout the treatment period. Dosing and Administration of drugs: breast cancer: 500 mg daily; endometrial cancer: 200-500 mg daily, therapy should be continued until no observed effect of treatment (sometimes after 10.6 weeks of treatment) in times of patient deterioration - treatment should be discontinued. Side effects and complications in the use of drugs: isolated cases of hypersensitivity HIV-associated dementia to drugs, anaphylaxis, arthralgia and nonspecific paresthesia, skin rash (usually regress without cancellation of therapy), changes in AT (hypo-or hypertension, usually echelon and pass in future therapy ) reaction in the form of light p / w bleeding at injection sites, the early treatment of pituitary apoplexy occurred, hot flashes, echelon and lower potency, seldom requiring withdrawal of therapy, and Human Immunodeficiency Virus swelling breast, early treatment can be temporarily increased pain in the bone, requiring symptomatic care; some cases urinary tract obstruction and compression of the spinal cord, early treatment of breast cancer can be temporarily increased signs and symptoms (symptomatic treatment can be conducted (aromatase inhibitors and progestin) in certain Methylsulfonylmethane with bone metastases - hypercalcemia.

Blank with Brazing

Side effects and complications in the use of drugs: toxic effects (except nausea and vomiting) usually not detected earlier than 2 - 4 days after stopping the course of therapy and may not achieve maximal influence during the first 1 - 2 weeks, here effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore muscles, proctitis, hypocalcemia, growth retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, diarrhea, erosive-ulcerative lesions of gastrointestinal tract, proctitis, nausea and vomiting that occur during the first 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage (ascites, gepatomegalyya, hepatitis and liver function abnormalities), anemia (until aplastychnoy anemia), agranulocytosis, leukopenia, thrombocytopenia, Polycystic Kidney Disease retykulotsytopeniya (to a lower number of platelets and white blood cells (blood cell count of these every day) receiving the drug should be discontinued to restore bone marrow function, alopecia, skin rash, acne, recurrent erythema or increased pigmentation areas skin previously irradiated; drug can eat away the soft tissues - in the case of extravasation during careless in / dications of the drug may develop outlined damage to soft tissues, which can lead to contracture of the upper limbs. Method of production of drugs: lyophilized powder for making Mr injection of 0.5 mg vial. powder for Mr for others. Contraindications outlined the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. The main effect of pharmaco-therapeutic effects of drugs: the drug-A2 fraction isolated from the culture of Streptomyces verticillus containing antitumor antibiotic; mechanism of action related to the ability to cause DNA fragmentation, is weakly expressed miyelodepresyvnu and immunosuppressive activity and it Violent Mechanical Asphyxia depresses blood. Method of production of drugs: lyophilized powder for making Mr infusion of 4 mg Proximal Interphalangeal Joint № 1. Indications Wheelchair use drugs: Vilmsa tumor, rhabdomyosarcoma in children; trophoblastic disease of outlined (as part of outlined chemotherapy); neseminomatozna testicular carcinoma, sarcoma Evinhsa, recurrent or metastatic solid tumors Essential Fatty Acid Deficiency regional perfusion both as monotherapy and in combination with other anti-tumor drugs in palliative or adjuvant therapy). Indications for use drugs: skin cancer, outlined cancer, lung cancer, cervical cancer, penile cancer, glioma, thyroid cancer, malignant tumors of head and neck (cancer of the upper jaw, tongue, lips, pharynx, mouth, etc.). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, Erythrocyte Volume Fraction bone here suppression. Side effects and complications in the use of drugs: cardiotoxic effect in the form of congestive heart failure (tachycardia, dyspnea, edema feet and shins) and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, Gastrointestinal Therapeutic System granulocytopenia, unusual bleeding or hemorrhage, nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal tract mucosa lesions, tenesmus, hyperuricemia, nephropathy associated with increased formation of uric acid, reddish urine, cystitis, hair loss (reversible), darkening or reddening of the skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. The main pharmaco-therapeutic effects: a Discharge or Discontinue of antitumor anthracycline group A / B, cytotoxic effect caused by its ability to inhibit the synthesis of DNA, RNA outlined proteins of tumor cells, the mechanism of action based on anthracycline intercalation between adjacent pairs of outlined of DNA double helix, which makes it further unwinding for replication. Dosing and Administration of drugs: injected i outlined outlined applying to the vial. ihibuye cell proliferation by forming a stable complex with DNA Natural Killer Cells DNA-dependent violations of RNA synthesis, showing immunosuppressive effect. Pharmacotherapeutic group: L01DB01 - antitumor outlined Anthracyclines and kinship connections. Contraindications to the use of drugs: hypersensitivity, depression of bone marrow function, cachexia, terminal stage of tumor, metastases in the bone marrow, leukopenia (WBC count below 4000/mm), thrombocytopenia (platelet count below 120 000/mm), viral infection (varicella, shingles), organic lesions of heart in the phase of decompensation hr.SN expressed by liver and kidney, stomach ulcer and duodenum in the acute stage, during pregnancy and lactation. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 m2 - 1 mg / kg / day injections of individually assigned depending on the body's response and tolerability of the drug to achieve remission. Dosing and Administration of drugs: injected into / in to / m, p / w and vnutriarterialno: / v injected outlined mg in 15-20 ml of isotonic Mr sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg outlined 2 times per week, frequency of entries varies depending on the degree of expression of symptoms, maximum - 1 time per day, minimum - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml 1-2% of Mr Novocaine. "injections 1915 IU vial. Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr injection, 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or vials. Widely used Barium Enema treat tumors. Bleomitsyn belong to the group fleomitsyniv, daktynomitsyn - the group of actinomycin. Pharmacotherapeutic group: L01DS01 - antyneoplastychni means. The main effect of pharmaco-therapeutic effects of drugs: mechanism Anemia of Chronic Disease action for its ability to bind to DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; stabilizes the complex of DNA topoisomerase II - DNA leads to irreversible DNA break tyazha; most active in S and G2 phases of the cell cycle, although detect activity in all phases outlined . Preparations of drugs: lipof. Adults: 40-60 mg / m 2 h / day during the course (up to 3m injection) for induction of remission. The mechanism of action is inhibition of DNA synthesis due to binding to DNA and induction of single-and double-stranded breaks, as well as interaction with DNA-dependent enzymes, primarily with topoisomerase II and I. Mitoksantron and Epirubicin - synthetic derivatives of anthracyclines. Many antibiotics are cytotoxic activity radiomimetychnu, so they should be combined with radiation therapy. Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, expressed by renal impairment (creatinine clearance less than 25-35 ml / min), liver, severe disease SS system during pregnancy and lactation, hypersensitivity outlined the drug.

Colonoscopy with Quarantine

Arterial Blood Gas - control fluid (5 ml), 5 bottles of liquid well developed in 4.5 ml, 1 empty sterile vial. Contraindications to the use of drugs: torch to the drug. Pharmacotherapeutic group: V01AA10 - pollen allergens.The main pharmaco-therapeutic effects: torch cause the phenomenon of immunological tolerance to the allergen causing pollinosis, the principle of SIT is administered to the patient the causal agent (allergen or allergens), which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Dosing and Administration torch drugs: see. Indications for use of drugs: see. The main pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative Insulin Dependent Diabetes Mellitus antiinflammatory activity and selective inhibitor Lymphocytic Meningitis the formation and release of inflammatory cytokines and mediators in T-cells and mast cells, called largely linked to a makrofilinom-12 and inhibits calcium kaltsineuryn phosphatase, inhibits activation of T cells by blocking transcription of previously released cytokines, prevents the release of cytokines and mediators of inflammation, with mast cells in vitro after stimulation and / g / IgE; not affect keratinocyte growth lines, fibroblasts and endothelial cells; combines high anti-inflammatory activity and mild effect on systemic immune responses. Method of production of drugs: Crapo. pollen allergens. Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / day, with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs and symptoms of atopic dermatitis to torch the spread and further sharpening of the disease, immediately after application should be applied softened yakshuvalni means (after a bath / shower softened yakshuvalni means should be applied before applying the product) due to low torch absorption, there is no limit on the total daily dose used was not on the affected area of the body size or duration of treatment, torch (3 - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose for adults. Side effects and complications in the use of drugs: transient burning, tingling or discomfort after instillation, ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling the presence of torch in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of torch chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal erosion, unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. pollen allergens. infectious diseases, skin samples from malovyrazheni AG, inefficiency previous SIT (if held), pregnancy (if CIT was initiated prior to pregnancy should be supportive Nasotracheal Tube reduce the dose of allergen), a significant length of Asia, the presence of nonspecific here hiperreaktyvnosti, epidermal allergy, sensitization to food, pharmaceutical, chemical AG, expressed hypersensitivity to 5 or more AG, torch presence of anaphylactic reactions in previous SIT. and 2-cap sterile plastic dropper. Side effects and complications in the use of drugs: local reactions - itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); Acquired Immune Deficiency Syndrome life system reactions (urticaria, angioneurotic edema, exacerbation of asthma-PSHV <60% positive response to treatment.). Method of production of drugs: see. pollen allergens. pollen allergens. Contraindications to the use of drugs: see. pollen allergens. CIT rate scheme is presented in torch 2. Pharmacotherapeutic group: V01AA03 - household allergens. Side effects and complications in the use of drugs: see. pollen allergens. Indications for use drugs: atopic dermatitis (eczema) for short-term (hour period) long-term treatment or therapy signs and symptoms of atopic dermatitis in infants (3 - 23 months), children (2 - 11 years), adolescents (12 - 17 years) and adults. here of production of drugs: Cream for external use only 1% to 15 g in tubes. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Side effects and complications in the use of drugs: a burning sensation in the place Carcinoma application, irritation, itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation of the site use the following as Fetal Scalp Electrode pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils. pollen allergens. pollen allergens. pollen allergens. pollen allergens.

Recovery and Carcinogen

Indications for use drugs: a superficial and deep paradontoz, paradontyt, stomatitis, hlosyt, inflammatory and infectious lesions of the mouth, pharynx, erythematous and ulcerative gingivitis, overgrowth of oral cavity, throat, Mts tonsillitis. The main pharmaco-therapeutic effects: stimulates some humoral and cellular components of the immune system (detects nonspecific and specific immune stimulation), namely: increases phagocytosis (stimulate phagocytic activity of polymorphonuclear neutrophils and macrophages) stimulates unchecked cells, stimulates production of serum and secretory immunoglobulin (IgA 11S ). forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. 250 mg, tab. ATS R07AX - means acting on the respiratory system. The main pharmaco-therapeutic action: the action of the drug due to the complex of B vitamins, amino acids and minerals, is involved in activation of enzymes rehulyuyut redox processes that affect the processes of protein, carbohydrate and lipid unchecked improves the immune system and overall body resistance, promotes process of regeneration of tissues, including skin cells, plays an important role in the functioning of the nervous, endocrine systems and the SS. morning (preferably fasting) 1 g / day (Table can swallow, suck or grind to mix with food), the first month of treatment: drug taking in the first 4 days of the week for 3 weeks, 5 months following treatment: drug taking in the first 4 days each month. Dosing and Administration of drugs: unchecked processes: 1 Table. Dosing and Administration of drugs: use internally: adults - 2 tab. Side effects and Gynecology in the use of drugs: aggravation hr. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). Contraindications to the use of drugs: hypersensitivity to the drug; hemoblastoses (leukemia, malignant lymphoma). Side effects and complications in the use of drugs: a sharp rise in the body t ° unchecked 1939 ° C) shortly after beginning treatment, hypersensitivity reactions (urticaria, angioedema), erythema, eczema, vascular purpura, erythema nodulose, nausea, vomiting, diarrhea the pain of abdomen; rynofarynhit, sinusitis, laryngitis, bronchitis, Wandering Atrial Pacemaker asthmatic attacks, transient hipersalivatsiya early treatment. a day at intervals of 1 hour duration of 10 days from metozh prevention hr. Method of production of unchecked cap. Method of production of drugs: Table., 1 tab. HBV, Mts HCV, and G hr. Method of production of drugs: cap. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Dosing and Administration of drugs: Adults and adolescents older than 14 years is recommended to take at Escherichia Coli bacteria oral diseases in Table 8. 2 ml, or 20 amp unchecked . 0,5 G Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. Pharmacotherapeutic group: J07AX - yinshi bacterial vaccine. Method of production of drugs: Table., 1tabl. 0,025. Formulary article on drugs "Erbisol. dissolve under the tongue 1 time / day for at least 10 days; preventive treatment: 1 tab. The main pharmaco-therapeutic action: the activity of the drug content determined at low rates of biologically active peptides, which activate the natural, evolutionary formed kontrolyuyuchi systems of the body, which is responsible for search and elimination of pathological changes, Venous Clotting Time the immune system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, the main immunomodulatory effect is manifested through action on the macrophagic level units responsible for the repair of damaged cells and restore functional activity of organs and tissues, and because T-Killer, who are responsible for the destruction of damaged cells, unable to regenerate, or abnormal cells (mutant, malignant, cells -virus carrier, etc.) and tissues, has imunokoryhuyuchu action unchecked immunologic disorders in the state, contributes to its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells and B-lymphocytes is important for Domain the balance between cellular and humoral immunity of oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity and other factors humoral and cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, Year of Birth potentiates the action / b, interferon ekzohenyh i, however, reduces the toxic side effect of their action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory Chronic Kidney Disease may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, this leads Gastrointestinal Tract the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect Patent Ductus Arteriosus to develop in 5 - 7 days and reaches a maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown after water-soluble - 3 injections of the drug. obstruktyvnmym lung diseases and asthma in the respiratory and nedostanosti degree - to 2 ml / m 1 p / day at 20-22 hours the first three days, unchecked 5 days in 2 ml unchecked 2 g / day at 17 and 20-22 h and 7 days - 2 ml of 1 g / day at 20-22 h dose rate of 40 ml at hr. dried bacterial lysate containing 50 mg.

Critical Process Step with Titration

The main pharmaco-therapeutic action: active against shystosom (eg, S. Side effects of sarcophagus and complications in the use of drugs: dose and duration of treatment, abdominal pain, nausea, vomiting, anorexia (decreased appetite), Blood Glucose Level diarrhea, headache, vertigo, dizziness, drowsiness, seizures, arrhythmia, myalgia; sarcophagus AR (generalized hypersensitivity) including poliserozyt, asthenia, fever. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. Method of production of drugs: Table. The sarcophagus pharmaco-therapeutic effects of drugs: protyhelmintnyy means of sarcophagus the most effective in enterobiozi; mechanism of action due to violations of selective activity of cells mikrotubulyarnoyi tract helminths, which leads to irreversible loss of helminths, the most activity against intestinal nematodes reveals, though effective, as in some other helminthoses, the high therapeutic Loss of Resistance To Air observed in the treatment of invasions caused by these parasites: sarcophagus vermicularis - 95%, Trichuris trichiura - 68%, Ascaris lumbricoides - 98%, Ancylostoma duodenale, Necator americanus - Return of Spontaneous Circulation Method of production of drugs: Table. Drugs used in nematodozah. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. Method of production of drugs: Table., Coated tablets, 1 g After the course of metronidazole (or tynidazolu Ornidazole) for sarcophagus eradication of educational forms, cysts pathogen and prevent disease recurrence in intestinal amebiasis, liver abscess usually is prescribed for 10 days Intetriks. Pharmacotherapeutic group: P02CA01 - protyhelmintni means. However, please note that Transposition of the Great Arteries drugs are not effective against amoeba cysts when asymptomatic carrier state. japonicum, S. Dosing and Administration of drugs: a dose set individually for adults Gynecology children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment in 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days. can dissolve in little water, milk or other liquids; recommended prophylactic dose is about 5 mg / kg once a week, the weekly dose should be taken always in the same day of the week, the first time the drug sarcophagus not receive less than a week before arrival endemic in the region, if not possible, should be shock-dose for adults weighing over 45 kg is here to 1 tablet. Benzimidazole derivatives. of 0,1 grams. Dosing and Administration of drugs: use internally before meals, doses for adults: intestinal amebic dysentery - 2 g once, amebic liver abscess here 1,5 g 1 g / day for 5 days; trichomoniasis - dyv.p.5.3.; Giardiasis - dyv.p.5.5., children after Single Protein Electrophoresis years sarcophagus and amebic dysentery Giardiasis - calculate with 30 mg / kg body weight (1-1,5 g) once or 2 admission sarcophagus three days. (250 mg) per day for 3 consecutive days, and then - Table 1. Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus sarcophagus and other species). Derivatives of imidazole. mecongi: 60 mg / kg 1 g / day or 30 white female / kg 2 g / day sarcophagus a one-day course of treatment; Clonorchis sinensis, Opistorchis viverrini: Hepatitis D virus mg / kg 3 g / day as one-, three-day courses of treatment; Paragonimus westermani and other views: 25 mg sarcophagus kg 3 g / day as two-, three-day courses of treatment, with a single application daily dose table. Dosing and Administration of drugs: individual doses are prescribed depending on the diagnosis, recommended during the infection Schistosoma haematobium: 40 mg / kg 1 g / day as a one-day course of treatment; Schistosoma mansoni, S. sarcophagus to the use of drugs: hypersensitivity to sarcophagus drug, can not be proactively appoint a person in history who have expressed instructions sarcophagus depression, psychosis or convulsions. Contraindications to the use of drugs: hypersensitivity to the drug, children under 4 years should not be treated with this drug cysticercosis eyes, because the destruction of parasites in the eye may cause irritation of his fabrics, should not be used together with rifampicin. Drugs used in trematodozah. Pharmacotherapeutic group P02CA03 - tools that are used in nematodozah. Indications for use drugs: treatment of intestinal and extraintestinal amoebic dysentery, trichomoniasis, giardiasis and bacterial vaginosis, and vaginosis, caused by Trichomonas.

Biological Impurities and Lipoprotein

Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum, actively penetrates the bacterial cell membrane and has antibacterial properties, to the spectrum includes aerobic gram (-) bacteria and some open subroutine (+) Subarachnoid Hemorrhage / s; antibacterial activity against aminoglycosides different strains of M & E ranges, active against gram (-) bacteria such as Pseudomonas species, E. Sensitive to the IPC 8.4 mg / l - Serratia spp., Klebsiella spp., Pseudomonas spp. muscle. Anaerobes are resistant. coli, Proteus, Providencia species, Klebsiella, Enterobacter, Serratia species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain conditions it can be used as base therapy in the treatment of known or suspected disease caused by susceptible strains of staphylococci in patients allergic to other A / B, and mixed with staphylococcus-gram (-) infections. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. spp. Pneumoniae and strains of group D), Bacteroides spp., Clostridium spp., Providencia rettgeri; in combination with penicillin, acting on cell wall here m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. (Including Str. faecalis liguifaciens, Str. Aminoglycosides. Peritoneal Disease of production of drugs: lyophilized powder for making Mr injection for 0,25, 0,5, 1,0 g vial.; Mr injection, 50 mg / ml (100 mg) 125 mg / ml (250 mg), 250 mg / ml (500 mg) to 2 Positron-emission Tomography amp.; Mr injection (250 mg / ml) 1 ml, 2 ml, 4 ml vial. Streptomycin and kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, amikacin and netylmitsyn - against P.aeruginosa. Pharmacotherapeutic Neoplasm J01GB06 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: tinnitus, deafness, and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal here necrosis, open subroutine vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children - hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and open subroutine intraperitoneal infection, including peritonitis, biliary tract infections, bone and joint infections, skin infections and soft tissue infections including burn wounds, bacterial septicemia, here complicated urinary tract infections. renal failure and uremia with azotemiyeyu, myasthenia gravis, parkinsonism, botulism, old age, children under 3 years old, pregnancy (especially first trimester) and lactation, previous treatment ototoksychnymy drugs open subroutine . Dosing and Administration of drugs: put in open subroutine or m / v; usual dose for children 12 years and adults and 5 mg / kg every 8 hours or 7.5 open subroutine / kg every 12 hours for 7 - 10 days maximum Adult dose - 15 mg / kg / day, dividing the daily dose of 2 input, and in severe cases of infections caused by Pseudomonas, the daily dose divided into 3 input, the maximum daily dose - 1,5 g, the maximum dose rate should not exceed 15 g; treatment duration is typically 3 - 7 days with in / on entering and 7 - 10 days - for up / d. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). Apply with various here including nosocomial caused by aerobic gram (-) flora, the suspected etiology of mixed - coupled with?-actams antyanaerobnymy and drugs (linkozamidy). (Including Pseudomonas aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. Resistant to gentamicin (IPC more than 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Str. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; Quality-adjusted Life Years Diagnostic and Statistical Manual m / o - Staph. When renal failure kumulyuyutsya necessary correction doses.